European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 5.36
0.00 (0.00%)
Feb 9, 2026, 2:18 PM CET
EBR:ALEMS Market Cap
EBR:ALEMS has a market cap or net worth of €22.68 million as of February 10, 2026. Its market cap has decreased by -12.86% in one year.
Market Cap
22.68M
Enterprise Value
39.10M
Revenue
49.47M
Ranking
n/a
PE Ratio
19.33
Stock Price
€5.36
Market Cap Chart
Since May 11, 2016, EBR:ALEMS's market cap has decreased from 86.09M to 22.68M, a decrease of -73.66%. That is a compound annual growth rate of -12.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 22.68M | 3.06% |
| Dec 31, 2025 | 22.01M | -13.33% |
| Dec 31, 2024 | 25.39M | -27.47% |
| Dec 29, 2023 | 35.01M | -57.73% |
| Dec 30, 2022 | 82.82M | 1,588.91% |
| Dec 31, 2021 | 4.90M | 0.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 49.78B |
| argenx SE | 42.57B |
| Financière de Tubize | 10.02B |
| Hyloris Pharmaceuticals | 207.20M |
| Onward Medical | 183.88M |
| Celyad Oncology | 8.06M |
| BioSenic | 1.50M |
| Oxurion NV | 490.69K |